학술논문

Aldafermin quantitatively improves inflammation in a 24-week clinical trial in patients with nonalcoholic steatohepatitis
Document Type
Journal
Source
JOURNAL OF HEPATOLOGY; JUL 2022, 77 pS443-pS443, 1p. Supplement: 1
Subject
Language
English
ISSN
16000641